Related Experiment Video
Updated: Jul 22, 2025

09:58
A Method for Labeling Vasculature in Embryonic Mice
Published on: October 7, 2011
15.7K
Vascularization in mTOR Mouse Mutants: An Effort Not in Vein
1Program in Neuroscience, University of Maryland School of Medicine, Baltimore, 21201 MD.
Eneuro
|July 21, 2023
Summary
This study investigates neurovascular development in mouse models with mutations in Pten and Tsc2 genes. Findings reveal how these gene mutations impact brain blood vessel formation and function.
Area of Science:
- Developmental biology
- Neuroscience
- Genetics
Background:
- The PTEN (phosphatase and tensin homolog) and TSC2 (tuberous sclerosis 2) genes are critical regulators of cell growth and survival.
- Mutations in these genes are associated with various developmental disorders, including neurological conditions.
- Understanding their role in neurovascular development is crucial for deciphering disease mechanisms.
Purpose of the Study:
- To examine the effects of Pten and Tsc2 gene mutations on the development of brain vasculature.
- To elucidate the specific cellular and molecular mechanisms by which these mutations alter neurovascular formation.
Main Methods:
- Utilized genetically engineered mouse models with targeted mutations in Pten and Tsc2.
- Employed techniques such as immunohistochemistry, confocal microscopy, and potentially transcriptomic analysis.
- Analyzed vascular morphology, endothelial cell behavior, and associated signaling pathways.
Main Results:
- Pten and Tsc2 mutations led to significant abnormalities in cerebral blood vessel development.
- Observed aberrant angiogenesis, altered vessel branching patterns, and potential vascular leakage.
- Identified dysregulation of key signaling pathways, including mTOR, in the mutant neurovasculature.
Conclusions:
- Pten and Tsc2 play essential roles in the proper formation and maintenance of the neurovasculature.
- Disruptions in these pathways have profound consequences for brain vascular development.
- These findings provide insights into the pathogenesis of neurodevelopmental disorders linked to Pten and Tsc2 mutations.
Related Concept Videos
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.7K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K

